Why the study?
Does increased time outside the target INR range increase the risk of mortality and thromboembolic events in patients with non-valvular atrial fibrillation?
Observational (n=2,223)
Does increased time outside the target INR range increase the risk of mortality and thromboembolic events in patients with non-valvular atrial fibrillation?
In patients with NVAF, increased time outside the therapeutic INR range is significantly associated with higher risks of mortality, ischemic stroke, and thromboembolic events.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Anwar Chennakkadan Varghese (2005) conducted an observational in Non-valvar atrial fibrillation (NVAF) (n=2,223). Time outside the target INR range vs. Time within target INR range was evaluated on Mortality (OR 1.29, p=<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: